Tinnitus With Normal Hearing Population: A Retrospective Chart Review of High Frequency Audiometry, Quality of Life and Laboratory Findings

Amaç: Tinnitus otolaringoloji pratiğinde sık karşılaştığımız bir semptom olup genellikle işitme kaybına eşlik eder. Bu çalışmada, işitme düzeyleri normal sınırlarda olan tinnitus hastalarında özelikle yüksek frekans işitmedeki erkendönem etkilenmeler,altta yatan olası faktörler ve tinnitus anketleri ile morbiditenin ortaya konması hedeflenmiştir. Yöntem ve Gereçler: İşitme kaybı tariflemeyen tinnituslu 62 hasta ile, tinnitusu olmayan 43 vakalık bir kontrolgrubu verileri, retrospektif olarak incelenmiştir. Hastalara ait yüksek frekansları da içeren odyometri ve rutin kantestleri analiz edilmiştir. Kuk ve Ohsaki anketleri ile tinnitus hastalarının yaşam kalitesi değerlendirmesi yapılmıştır. Bulgular: Biyokimyasal veriler karşılaştırıldığında, tinnitus grubunda HDL düzeylerinin belirgin olarak düşük oldu- ğu bulunmuştur (p=0.011). Dört ve 8 kHz deki işitme eşikleri tinnitus grubunda anlamlı düzeyde azalmıştır(sırasıyla p=0,004 and p=0,002). Tinnitus süresini 90 gün ve üzeri tarifleyen vakaların işitme eşikleri ≤90 gruba göre 4,8 ve12,5 kHz. de belirgin olarak düşüktür(p

Normal İşiten Popülasyonda Tinnitus: Yüksek Frekans Odyometri,Yaşam Kalitesi Anketleri ve Laboratuvar Bulgularının Retrospektif İncelenmesi

Aim: Tinnitus is a common symptom in otolaryngology practise and usually accompanied to hearing loss. The pre- sent study focused on tinnitus patients with normal hearing levels to find out especially early onset high frequencylosses, reconsider the possible precipitating factors and expose the morbidity of tinnitus with questionnaries. Material and Methods: A retrospective chart review of 62 tinnitus patients who deny hearing loss and 43 patientswithout tinnitus as control group are enrolled to this study. The data of audiometric evaluation with high frequenciesand blood tests are analysed. Kuk and Ohsaki questionnaries obtained from tinnitus patients to evaluate the qualityof life impairment. Subjects with Meniere s disease,depression,anxiety disorders, tinnitus following acoustic traumaare excluded from the study. Results: Comparison of biochemical findings between tinnitus and control group showed that HDL levels werestatistically lower in tinnitus group(p=0.011). Hearing impairment at 4 and 8 kHz in tinnitus group was worse thancontrol group.(p=0,004 and p=0,002 respectively).Patients who have tinnitus over 90 days have worse outcome in4,8 and 12,5 kHz. than ≤ 90 days.(p

___

  • 1. American Tinnitus Association.www.ATA.org. accessed in September, 2009. 2. Ochi K, Ohashi T, Kenmochi M. Hearing impairment and tinnitus pitch in patients with unilateral tinnitus: comparison of sudden hearing loss and chronic tinnitus. Laryngoscope 2003; 113: 427-31. 3. Olzowy B, Canis M, Hempel JM, et al. Effect of atorvastatin on progression of sensorineural hearing loss and tinnitus in the elderly: results of a prospective, randomized, double-blind clinical trial. Otol Neurotol 2007; 28: 455-8. 4. Du Z, Yang Y, Hu Y, et al. A long-term high-fat diet increases oxidative stress, mitochondrial damage and apoptosis in the inner ear of D-galactose-induced aging rats. Hear Res 2012; 287:15-24. 5. Aimoni C, Bianchini C, Borin M, et al. Diabetes, cardiovascular risk factors and idiopathic sudden sensorineural hearing loss: a case-control study. Audiol Neurootol 2010; 15: 111-5. 6. Campos GR, Moura KH, Sarmento CT, et al. Is the Degree of Discomfort Caused by Tinnitus in Normal-Hearing Individuals Correlated with Psychiatric Disorders? Otolaryngol Head Neck Surg 2013; 48: 658-63. 7. Zirke N, Seydel C, Szczepek AJ, et al. Psychological comorbidity in patients with chronic tinnitus: analysis and comparison with chronic pain, asthma or atopic dermatitis patients. Qual Life Res 2013; 22: 263-72. 8. Das SK, Wineland A, Kallogjeri D, Piccirillo JF. Cognitive speed as an objective measure of tinnitus. Laryngoscope 2012; 122: 2533-8. 9. Monzani D, Barillari MR, Alicandri Ciufelli M, et al. Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience. Acta Otorhinolaryngol Ital 2012; 32: 393-403. 10. Kuk FK, Tyler RS, Russell D, Jordan H. The psychometric properties of a tinnitus handicap questionnaire.Ear Hear. 1990; 11: 434-45. 11. Ohsaki K, Ueno M, Zheng HX, et al. Evaluation of tinnitus patients by peroral multi-drug treatment. Auris Nasus Larynx 1998; 25: 149-54. 12. Crocetti A, Forti S, Ambrosetti U, Bo LD. Questionnaires to evaluate anxiety and depressive levels in tinnitus patients. Otolaryngol Head Neck Surg 2009; 140: 403-5. 13. Almeida TA, Samelli AG, Mecca Fdel N, et al. Tinnitus sensation pre and post nutritional intervention in metabolic disorders. Pro Fono 2009; 21: 291-7. 14. Shemesh Z, Attias J, Ornan M, et al. Vitamin B12 deficiency in patients with chronic-tinnitus and noise-induced hearing loss. Am J Otolaryngol 1993; 14: 94-9. 15. Cai Q, Du X, Zhou B, et al. Effects of simvastatin on plasma lipoproteins and hearing loss in apolipoprotein E gene-deficient mice.ORL J Otorhinolaryngol Relat Spec 2009; 71: 244-50. 16. Saito T, Sato K, Saito H. An experimental study of auditory dysfunction associated with hyperlipoproteinemia. Arch Otorhinolaryngol 1986; 243: 242-5. 17. Sutbas A, Yetiser S, Satar B, et al. Low-cholesterol diet and antilipid therapy in managing tinnitus and hearing loss in patients with noise-induced hearing loss and hyperlipidemia. Int Tinnitus J 2007; 13: 143-9. 18. M-Shirazi M, Farhadi M, Jalessi M, et al. Prevalence of dyslipidemia among Iranian patients with idiopathic tinnitus. J Res Med Sci 2011; 16: 890-6. 19. Suckfüll M, Hearing Loss Study Group. Fibrinogen and LDL apheresis in treatment of sudden hearing loss: a randomised multicentre trial. Lancet. 2002; 360:1811-7. Erratum in: Lancet; 361: 1916. 20. Kariya S, Cureoglu S, Fukushima H, et al. Comparing the cochlear spiral modiolar artery in type-1 and type-2 diabetes mellitus:a human temporal bone study. Acta Med Okayama 2010; 64: 375-83. 21. Fujita T, Yamashita D, Katsunuma S, et al. Increased inner ear susceptibility to noise injury in mice with streptozotocin-induced diabetes. Diabetes 2012; 61: 2980-6. 22. Hamed SA, El-Attar AM. Cochlear dysfunction in hyperuricemia: otoacoustic emission analysis.Am J Otolaryngol 2010; 31: 154-61. 23. Sun AH, Li JY, Xiao SZ, et al. Changes in the cochlear iron enzymes and adenosine triphosphatase in experimental iron deficiency. Ann Otol Rhinol Laryngol 1990; 99: 988–92. 24. Sun AH, Wang ZM, Xiao SZ, et al. Sudden sensorineural hearing loss induced by experimental iron deficiency in rats. ORL 1992; 54:246–50. 25. Ochi K, Kinoshita H, Kenmochi M, et al. Zinc deficiency and tinnitus. Auris Nasus Larynx 2003; 30: S25-8. 26. Gopinath B, McMahon CM, Rochtchina E, et al. Incidence, persistence, and progression of tinnitus symptoms in older adults: the Blue Mountains Hearing Study. Ear Hear 2010; 31: 407-12. 27. Vanneste S, To WT, De Ridder D. The psychometric properties of the Tinnitus Handicap Questionnaire in a Dutch-speaking population. Clin Otolaryngol 2011; 36: 9-16.